Sorrento Therapeutics, Inc. (SRNE)
OTCMKTS
· Delayed Price · Currency is USD
0.0032
0.00 (0.00%)
Oct 16, 2024, 3:56 PM EDT
Sorrento Therapeutics Revenue
Sorrento Therapeutics had revenue of $15.03M in the quarter ending June 30, 2023, with 31.10% growth. This brings the company's revenue in the last twelve months to $64.27M, up 16.89% year-over-year. In the year 2022, Sorrento Therapeutics had annual revenue of $62.84M with 18.78% growth.
Revenue (ttm)
64.27M
Revenue Growth
+16.89%
P/S Ratio
0.03
Revenue / Employee
67.72K
Employees
949
Market Cap
1.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 62.84M | 9.94M | 18.78% |
| Dec 31, 2021 | 52.90M | 12.92M | 32.31% |
| Dec 31, 2020 | 39.99M | 8.55M | 27.21% |
| Dec 31, 2019 | 31.43M | 10.24M | 48.31% |
| Dec 31, 2018 | 21.19M | -130.66M | -86.04% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.69B |
| Ryman Healthcare Limited | 411.39M |
| Verano Holdings Corp. | 920.97M |
| Vireo Growth Inc. | 98.04M |
| Medexus Pharmaceuticals Inc. | 108.78M |
Sorrento Therapeutics News
- 6 weeks ago - Sorrento Therapeutics Restructuring Chief Hosted Party for Judges Who Later Oversaw Its Liquidation - The Wall Street Journal
- 6 weeks ago - Sorrento Resources Announces Appointment of Alex Bugden as President and Chief Executive Officer - Newsfile Corp
- 5 months ago - Sorrento Resources to Sell Three Newfoundland Properties to Gold Hunter - Newsfile Corp
- 5 months ago - Sorrento Resources Announces Appointment of Alex Bugden as a Director and Qualified Person - Newsfile Corp
- 6 months ago - DSI Introduces Westbury(R) Sorrento Aluminum and Stainless Steel Mesh Railing - Newsfile Corp
- 8 months ago - Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc. - Business Wire
- 1 year ago - Sorrento Therapeutics, Inc. Announces Auction for Sale of Scilex Securities and Bankruptcy Court Approval of Stalking Horse Bid - PRNewsWire
- 1 year ago - Scilex: Sorrento's Better Half, Or Its Entangled, Erratic Mover? - Seeking Alpha